These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8393636)

  • 1. Neonatal varicella exposure risk score (NeVERS).
    Rathore MH; Gordon VE; Garrison RD
    Am J Infect Control; 1993 Jun; 21(3):163-4. PubMed ID: 8393636
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of varicella exposures in the neonatal intensive care unit.
    Gold WL; Boulton JE; Goldman C; Gershon A; Steinberg SP; Chua R; Low DE; McGeer A
    Pediatr Infect Dis J; 1993 Nov; 12(11):954-5. PubMed ID: 8265289
    [No Abstract]   [Full Text] [Related]  

  • 3. Varicella zoster virus antibody titers before and after administration of zoster immune globulin to neonates in an intensive care nursery.
    Wang EE; Prober CG; Arvin AM
    J Pediatr; 1983 Jul; 103(1):113-4. PubMed ID: 6306191
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of varicella exposure in a neonatal intensive care unit.
    Lipton SV; Brunell PA
    JAMA; 1989 Mar 24-31; 261(12):1782-4. PubMed ID: 2537441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella exposure in a neonatal intensive care unit: case report and control measures.
    Stover BH; Cost KM; Hamm C; Adams G; Cook LN
    Am J Infect Control; 1988 Aug; 16(4):167-72. PubMed ID: 2847598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.
    Miller E; Cradock-Watson JE; Ridehalgh MK
    Lancet; 1989 Aug; 2(8659):371-3. PubMed ID: 2569560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella exposure in a neonatal intensive care unit: emergency management and control measures.
    Ng PC; Lyon DJ; Wong MY; Fok TF; Wong W; Cheung KL; Tam JS; Cheng AF
    J Hosp Infect; 1996 Mar; 32(3):229-36. PubMed ID: 8690886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of varicella in a newborn intensive care nursery.
    Gustafson TL; Shehab Z; Brunell PA
    Am J Dis Child; 1984 Jun; 138(6):548-50. PubMed ID: 6720640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Contact infection from live varicella vaccine recipients.
    Asano Y; Yazaki T; Ito S; Isomura S; Takahashi M
    Lancet; 1976 May; 1(7966):965. PubMed ID: 57366
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoster immune plasma prophylaxis of varicella: a follow-up report.
    Balfour HH; Groth KE
    J Pediatr; 1979 May; 94(5):743-6. PubMed ID: 221631
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin prophylaxis for infants exposed to varicella in a neonatal unit.
    Patou G; Midgley P; Meurisse EV; Feldman RG
    J Infect; 1990 May; 20(3):207-13. PubMed ID: 2341729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal varicella-zoster infection in a newborn treated with varicella-zoster immunoglobulin.
    King SM; Gorensek M; Ford-Jones EL; Read SE
    Pediatr Infect Dis; 1986; 5(5):588-9. PubMed ID: 3020522
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chickenpox prevention in patients at risk with a special immunoglobulin].
    Thomas E; Enders-Ruckle G; Geursen RG
    Klin Padiatr; 1985; 197(5):415-8. PubMed ID: 2999501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Active immunization of children exposed to varicella infection in hospitals, using subcutaneous and intradermal attenuated live vaccine].
    Boda D; Bartyik K; Szüts P; Turi S
    Orv Hetil; 1985 Oct; 126(42):2577-80. PubMed ID: 2997687
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of specific intravenous varicella-zoster immunoglobulins in the prevention of varicella in immunocompromised children: clinical and serological evaluation].
    Macchia P; Favre C; Nardi M; Consolini R; Conaldi PG; Bendinelli M
    Minerva Pediatr; 1987 Oct; 39(20):813-20. PubMed ID: 2830480
    [No Abstract]   [Full Text] [Related]  

  • 18. [A complicated varicella infection].
    Schirm J; Manson WL; Schröder FP
    Ned Tijdschr Geneeskd; 1990 Oct; 134(40):1966. PubMed ID: 2172844
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for hospital visitation by recipients of varicella vaccine.
    Dennehy PH
    Pediatr Infect Dis J; 1996 May; 15(5):475. PubMed ID: 8724081
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of varicella-zoster immunoglobulin in modification of severe congenital varicella.
    Bakshi SS; Miller TC; Kaplan M; Hammerschlag MR; Prince A; Gershon AA
    Pediatr Infect Dis; 1986; 5(6):699-702. PubMed ID: 3025821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.